Please login to the form below
Astellas Pharma
This page shows the latest Astellas Pharma news and features for those working in and with pharma, biotech and healthcare.
China first market to approve AZ’s kidney drug roxadustat
AZ and FibroGen have rights to roxadustat in the US, China and other world markets, while Astellas Pharma will sell the drug in Europe and Japan.
Latest news
-
Astellas, Catalyst approvals set up record year for FDA approvals
The approvals of Astellas’ FLT3 inhibitor Xospata (gilteritinib) for acute myeloid leukaemia and Catalyst Pharmaceuticals’ Firdapse (amifampridine) for rare autoimmune disease Lambert-Eaton Myasthenic Syndrome (LEMS), already put the number for
-
Astellas makes another gene therapy play with Juventas deal
Astellas says that faecal incontinence is widespread and has no effective treatments, severely impacting the quality of life of patients with the disorder. ... We are excited to partner with Astellas to advance the programme for treatment of patients
-
Daily Brief: Orchard raises $150m, Astellas swoops for early-stage gene company, Amicus gets FDA Fabry approval
Astellas acquires UK gene therapy company Quethera. Japan’s Astellas Pharma is to acquire UK-based gene therapy company Quethera for $85m. ... Yasukawa, Ph.D., who took over as president and CEO of Astellas in February.
-
Daily Brief: Immunotherapy combos dominate ASCO, Pharma's Brexit warning, Big data and prostate cancer
The European Union’s Innovative Medicines Initiative (IMI) has been around 10 years, and has produced some major research collaborations between pharma, biotech and academics. ... Alex Asiimwe, Director and Global TA head, epidemiology, Bayer. The
-
J&J’s Erleada first US drug for non-metastatic prostate cancer
It also gives J&J a leg-up in what looks set to be a big market tussle with Pfizer and Astellas and their Xtandi (enzalutamide) product, which has also been ... J&J acquired Erleada when it took over Aragon Pharma in 2013 in a deal valued at $1bn.
More from news
Approximately 1 fully matching, plus 123 partially matching documents found.
Latest Intelligence
-
Getting multichannel marketing right
How the atomisation of communication is challenging and benefiting pharma. The habits and priorities of the purchasers, prescribers and users of medicines are changing rapidly. ... They’re not going to want it in a month, much less six months,” Chad
-
The good, the bad and the ugly
AstraZeneca, Takeda, Astellas Pharma, Novo Nordisk and Recordati take up the final five positions, though only two - Takeda (3.9%) and Astellas (9.3%) - recorded growth. ... The data this article was based on is available in full online:
-
Case study: Action on Fistula
Client:Astellas Pharma EMEA Limited. Agency:Forster Communications. Campaign:Action on Fistula. Timescale:. Action on Fistula, launched in May 2014, is an innovative partnership between Astellas Pharma EMEA Limited and the ... Astellas’ investment in
-
Japanese pharma pulls no punches with post-Brexit UK
Yasuo Sakae, vice president of corporate strategy and planning at Astellas Pharma Europe, told PME that the company’s regulatory team for the Europe, Middle East and Africa (EMEA) region is ... globally, as well as the presence of world-class
-
Deal Watch July 2016
$225m. $36m. LEO Pharma. AstraZeneca. $1, 115m. $115m. Astellas. Cytokinetics. $100m. ... In at numbers 2, 3 and 4 are the LEO-AstraZeneca deal with an upfront of $115m, Astellas-Cytokinetics at $95m and Almirall-Sun Pharma at $50m (see below).
More from intelligence
Approximately 1 fully matching, plus 21 partially matching documents found.
Latest appointments
-
Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
Taylor joins the agency from Astellas, where she was senior director of corporate communications, EMEA. ... run those very departments in global pharma companies and we therefore completely understand the challenges they face.
-
Astellas strengthens US and Canadian leadership team
Astellas has promoted Steve Sabus (pictured right) to general manager of Astellas Pharma Canada, effective from 1 April this year. ... needs.”. Sabus joined Astellas in 2007 and has over 25 years’ experience in the pharmaceutical industry.
-
Astellas promotes Anthony Fiordaliso to VP, Americas finance
He first joined the pharma firm in 2010 from Schering-Plough. Astellas has promoted Anthony Fiodaliso to VP, Americas finance to oversee areas such as managerial reporting and budgeting, financial planning ... In his new role Fiordaliso will report
-
Dendreon appoints new R&D lead
Joining from Astellas Pharma, Dr Brown most recently served as senior medical director of oncology, where he led US medical strategy for the prostate cancer drug Xtandi (enzalutamide).
-
Astellas appoints new senior VP
Astellas.”. “I’m confident she will make an immediate and positive impact on both the team in the Americas, as well as the patients and partners we serve.”. ... She has also received multiple awards for leadership and innovation through her career
More from appointments
Approximately 0 fully matching, plus 29 partially matching documents found.
Latest from PMHub
-
emotive boosts health economics and outcomes research team
Since joining emotive in May 2014, he has played a key role in the delivery of a range of creative health economics solutions for a variety of pharma clients, across different ... major pharma clients, including Bayer and Astellas.
-
How to integrate data to drive sales
Inspired by a recent Agnitio roundtable discussion with Allergan, Ariad Pharmaceuticals, Astellas and Ipsen Pharma. As the number of our digital channels and tools continually expand, there are many opportunities to
-
World’s Largest Pharmaceutical Summit Brings Latest Innovations To Light In New Award Ceremony
Astellas Pharma, Bayer, Pfizer and MSD are amongst the shortlisted companies who will join an exclusive celebration to recognise what really matters when it comes to supporting real patient outcomes. ... Customer Innovator Award and Lifetime Value
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
-
Digital Account Director
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
-
Health Consultant - Brand Comms
-
Competitive Salary
-
Account Director, Medical Education
-
Salary TBC
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Freelance AM/ AD Healthcare Advertising
-
£350-400 depending on experience
- Senior Account Manager, Medical Communications, London
-
Excellent package
- Scientific Director – Medical Communications
-
Salary TBC
- Freelance Senior Account Manager / Account Director - Healthcare...
-
£350-400 depending on experience
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
Subscribe to our email news alerts
- Blood disorder specialists Imara raises $63m
- NICE wants to stop saying ‘no’ – but needs pharma’s co-operation
- Three questions that should anchor your brand strategy
- Allergy Tx hit hard as birch pollen product stumbles
- Sanofi gets cardio outcomes claim for Praluent in EU
- Keytruda adds another NSCLC approval in Europe
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
- The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
- The Future of Pharma sales: fast forward to 2029
- Change is inevitable, and necessary, for growth in business....
- International Women's Day - 8 March 2019
- International Women's Day has been celebrated since its inception in 1911. But how far have we come?...
Quick links
Infographics
